# MMPs at Work: Deciphering Their Role in the Cellular Mechanisms of Orthodontic Tooth Movement

**Authors:** Mariana Ramos Patrão, Pedro Mariano Pereira, Jorge Caldeira, Madalena Salema-Oom

PMC · DOI: 10.3390/ijms27010542 · International Journal of Molecular Sciences · 2026-01-05

## TL;DR

This review explores how matrix metallopeptidases (MMPs) contribute to tooth movement during orthodontic treatment by remodeling the extracellular matrix and influencing cell behavior.

## Contribution

The paper provides a comprehensive review of recent findings on specific MMPs and their roles in periodontal ligament remodeling during orthodontic tooth movement.

## Key findings

- MMPs such as MMP-1, -2, -3, -8, -9, -12, -13, and -14 respond to mechanical forces and regulate collagen degradation.
- Periodontal ligament cells, hypoxia, and immune molecules like TNFα and TGF influence MMP-mediated tissue adaptation.
- Modulating the MMPs/TIMPs balance may improve orthodontic outcomes by enhancing tissue resorption and formation.

## Abstract

Matrix metallopeptidases (MMPs) are enzymes that, in balance with their inhibitors, play a vital role in extracellular matrix remodelling, particularly during orthodontic tooth movement (OTM). Despite growing interest, significant research is still required to fully comprehend the mechanisms and signalling pathways involved in periodontal ligament remodelling and OTM, particularly those mediated by MMPs. This review explores recent in vitro and in vivo evidence on how specific MMPs—namely, MMP-1, -2, -3, -8, -9, -12, -13, and -14—respond to compressive and tensile forces, regulate collagen degradation, and influence periodontal ligament fibroblast and osteoblast behaviour, ultimately shaping tissue resorption and formation. We also summarize the roles of periodontal ligament cells, hypoxia, the neurovascular and immune systems, and well-known molecules—including receptor activator of nuclear factor kappa β, receptor activator of nuclear factor kappa β ligand, osteoprotegerin, macrophage colony-stimulating factor, tumour necrosis factor α, transforming growth factor, and interleukins—in orchestrating these responses. Finally, we address the clinical relevance of these pathways, highlighting the potential for therapeutic strategies targeting MMPs activity. Overall, this review underscores the pivotal contribution of MMPs to extracellular matrix turnover and tissue adaptation during OTM and suggests that modulating the MMPs/tissue inhibitors of matrix metallopeptidase (TIMPs) balance may enhance orthodontic outcomes.

## Linked entities

- **Proteins:** MMP1 (matrix metallopeptidase 1), MMP2 (matrix metallopeptidase 2), MMP3 (matrix metallopeptidase 3), MMP8 (matrix metallopeptidase 8), MMP9 (matrix metallopeptidase 9), MMP12 (matrix metallopeptidase 12), MMP13 (matrix metallopeptidase 13), MMP14 (matrix metallopeptidase 14)

## Full-text entities

- **Genes:** TNFRSF11B (TNF receptor superfamily member 11b) [NCBI Gene 4982] {aka OCIF, OPG, PDB5, TR1}, TNFSF11 (TNF superfamily member 11) [NCBI Gene 8600] {aka CD254, ODF, OPGL, OPTB2, RANKL, TNLG6B}, TNFRSF11A (TNF receptor superfamily member 11a) [NCBI Gene 8792] {aka CD265, FEO, LOH18CR1, ODFR, OFE, OPTB7}
- **Diseases:** hypoxia (MESH:D000860), OTM (MESH:D014076)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12787207/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12787207/full.md

## References

223 references — full list in the complete paper: https://tomesphere.com/paper/PMC12787207/full.md

---
Source: https://tomesphere.com/paper/PMC12787207